Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

47.7K
Overview
47.7K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

42
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
42
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

12.9K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lineage-encoded genomic determinants of neonatal invasive Group B Streptococcal disease.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Management of <i>Coxiella burnetii</i> Endocarditis in a Child With Congenital Heart Disease.

Case reports in pediatrics·2026
Same author

CHildren of the Cohort Study (CHOC): Exploring parenting desire among people living with HIV in Switzerland.

HIV medicine·2026
Same author

Predicting trajectories of illness using RNA velocity of whole blood.

Nature communications·2026
Same author

[Devil's Advocate: Exclusive breastfeeding for six months - evidence-based gold standard or well-intentioned myth?]

Klinische Padiatrie·2026
Same author

Value of blood pressure for detecting serious illness in children attending acute care settings in low- and middle-income countries: a multicentre observational study.

Archives of disease in childhood·2026

Related Experiment Video

Updated: Oct 31, 2025

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
05:51

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain

Published on: July 24, 2016

20.0K

Striking Decrease of Enteroviral Meningitis in Children During the COVID-19 Pandemic.

Larissa Stoffel1, Philipp K A Agyeman1, Kristina Keitel2

  • 1Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Open Forum Infectious Diseases
|June 29, 2021
PubMed
Summary

In 2020, pediatric enteroviral meningitis vanished in Bern, Switzerland. This suggests public health measures against coronavirus disease 2019 may curb fecal-oral pathogen spread.

Keywords:
COVID-19EnterovirusSARS-CoV-2childepidemiologymeningitis

More Related Videos

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.5K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

833

Related Experiment Videos

Last Updated: Oct 31, 2025

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
05:51

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain

Published on: July 24, 2016

20.0K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.5K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

833

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Epidemiology

Background:

  • Enteroviral meningitis is a significant pediatric pathogen.
  • This infection is primarily transmitted via the fecal-oral route.
  • Public health measures were implemented globally in 2020 due to coronavirus disease 2019 (COVID-19).

Purpose of the Study:

  • To investigate the incidence of pediatric enteroviral meningitis in Bern, Switzerland during 2020.
  • To explore the potential impact of COVID-19 public health measures on enteroviral meningitis transmission.

Main Methods:

  • Retrospective analysis of pediatric enteroviral meningitis cases in Bern, Switzerland for the year 2020.
  • Comparison with historical incidence data (if available, though not explicitly stated in the abstract).

Main Results:

  • A complete absence of pediatric enteroviral meningitis cases was observed in Bern in 2020.
  • This represents an unprecedented finding for the region.

Conclusions:

  • The findings suggest that widespread nonpharmaceutical interventions (NPIs) implemented for COVID-19 may have inadvertently controlled the spread of enteroviruses.
  • Community-wide NPIs demonstrate potential for managing major pediatric pathogens transmitted through fecal-oral routes.